KEI request for investigation into anticompetitive aspects of Gilead Voluntary Licenses for patents on Tenofivir and Emtricitabine 12 February 2007 Federal Trade Commission Washington, DC Attn: Randy Marks

First Page		Document Content
Date: 2017-11-20 13:59:46		KEI request for investigation into anticompetitive aspects of Gilead Voluntary Licenses for patents on Tenofivir and Emtricitabine 12 February 2007 Federal Trade Commission Washington, DC Attn: Randy Marks Add to Reading List Source URL: www.keionline.org Download Document from Source Website File Size: 381,47 KB Share Document on Facebook